Ose, Jennifer http://orcid.org/0000-0002-2030-9676
Holowatyj, Andreana N.
Nattenmüller, Johanna
Gigic, Biljana
Lin, Tengda
Himbert, Caroline
Habermann, Nina
Achaintre, David
Scalbert, Augustin
Keski-Rahkonen, Pekka
Böhm, Jürgen
Schrotz-King, Petra
Schneider, Martin
Ulrich, Alexis
Kampman, Ellen
Weijenberg, Matty
Gsur, Andrea
Ueland, Per-Magne
Kauczor, Hans-Ulrich
Ulrich, Cornelia M.
Funding for this research was provided by:
ERA-NET Transcan (01KT1503, JTC 2012)
National Cancer Institute (R01 CA189184, R01 CA207371, U01 CA206110, P30 CA042014)
National Human Genome Research Institute (T32 HG008962)
Österreichischen Akademie der Wissenschaften (1578-B19)
Bundesministerium für Bildung und Forschung (01KT1512)
Institut National Du Cancer (2014-007)
Norges Forskningsråd (236564/H10)
KWF Kankerbestrijding
ZonMw (UW2013-6397)
Article History
Received: 30 September 2019
Accepted: 4 May 2020
First Online: 19 May 2020
Compliance with ethical standards
:
: C.M.U. has served as cancer center director oversight over research funded by several pharmaceutical companies, but has not received funding directly herself. The remaining authors declare no conflict of interest.